-

Haug Partners LLP Welcomes New Partner, Wan Chieh (Jenny) Lee

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP today announced that Wan Chieh (Jenny) Lee has joined the firm as a partner in its New York City office. Ms. Lee was formerly Counsel at Fay Kaplun & Marcin, LLP and was a Senior Associate at King & Spalding, LLP. Prior, she was as an Associate at Morgan & Finnegan, LLP.

Ms. Lee is an experienced patent attorney whose practice focuses on strategic counseling, procurement of worldwide patent rights, due diligence, freedom to operate, and intellectual property transactions. She has developed and executed patent procurement strategies that are aligned with clients’ immediate and long-term business goals, including product life cycle management under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act.

Ms. Lee has expertise in a broad range of life science technologies, including antibodies, vaccines, small molecule pharmaceuticals, diagnostics, veterinary formulations, data science, biomaterials and medical devices, as well as a variety of other technologies such as polymers, cosmetics, industrial chemicals, and manufacturing process controls.

“Jenny’s practice nicely complements our Firm’s focus in intellectual property, particularly in the life sciences. Her expertise in the area of patent procurement expands our presence before the U.S. Patent and Trademark Office. We are very excited to have Jenny practicing with us,” stated Managing Partner, Sandy Kuzmich, Ph.D.

Haug Partners LLP is a national law firm that provides integrated, multidisciplinary legal services in all aspects of intellectual property, as well as in FDA law, antitrust counseling, and commercial litigation. The firm has offices in New York, Washington, D.C., Boston, and West Palm Beach.

Contacts

Haug Partners LLP
Kyle B. Haug, 212-588-0800
khaug@haugpartners.com
www.haugpartners.com

Haug Partners LLP


Release Summary
Haug Partners LLP today announced that Wan Chieh (Jenny) Lee has joined the firm as a partner in its New York City office.
Release Versions

Contacts

Haug Partners LLP
Kyle B. Haug, 212-588-0800
khaug@haugpartners.com
www.haugpartners.com

Social Media Profiles
More News From Haug Partners LLP

Haug Partners Congratulates Ralph Labaton on Elevation to Partner

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to announce the elevation of Ralph Labaton to Partner as of January 1, 2024.. Ralph Labaton’s work focuses on antitrust litigation and other complex litigation matters. He has significant experience litigating class actions across multiple industries, including reverse payment and “pay-for-delay” pharmaceutical actions. Mr. Labaton also devotes his time to community efforts, including serving as a Member of the Young Professionals Committe...

Jennifer Patterson joins Haug Partners LLP’s Antitrust group

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to welcome Jennifer Patterson as a partner in its New York office. Ms. Patterson has more than 25 years of experience handling antitrust litigation and other complex commercial disputes across a wide range of industries including pharmaceuticals, rail freight transportation, publishing, auto parts, aircraft parts, biometric identification, poultry breeding, food additives, pesticides, optical film, flat glass manufacturing, and accounting...

Haug Partners Successfully Defends Takeda’s Vyvanse® Patents At Trial Against Generic Challenge

NEW YORK--(BUSINESS WIRE)--On December 27, 2022, Haug Partners LLP and Gibbons PC obtained a key victory as to all counts for its client, plaintiffs Takeda Pharmaceutical Co. Ltd. and Takeda Pharmaceuticals U.S.A., Inc., defeating a generic challenge by Norwich Pharmaceuticals Inc. to Takeda’s Orange Book-listed patents for Takeda’s multibillion dollar Vyvanse® product. In a 107-page Opinion, Judge Stanley R. Chesler (D.N.J.) found that Takeda prevailed on all fourteen asserted claims in the ma...
Back to Newsroom